Li ZUO, MD

Nephrologist

  • Professor of Medicine, Chief of Renal Division, Peking University People’s Hospital
  • President of Chinese Society of Blood Purification Administration

Jonathan BARRATT, PhD, FRCP

Nephrologist

  • Leader of Renal Research Group within the College of Life Sciences, University of Leicester
  • He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and a member of the steering committee for the International IgA Nephropathy Network
  • Member of the FDA and American Society of Nephrology Kidney Health Initiative: Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy Work group
  • Editorial Board member for Kidney International and Clinical Journal of the American Society of Nephrology
  • Co-Chair of the UK Glomerulonephritis Clinical Study Group and IgA nephropathy lead for the recent revision of the KDIGO Clinical Practice Guidelines for Glomerular Diseases

Junwei YANG, MD, PhD

Nephrologist

  • Professor of Medicine, Chief of Renal Division, Nanjing Medical University, 2nd Affiliated Hospital
  • President of Chinese Association of Pathophysiology Renal Committee

Johan ROSMAN, MD, PhD, FRACP

Nephrologist

  • Foundation Professor of Medicine, Curtin University Medical School, Australia
  • Active on several editorial boards and review committees and author of about 100 publications in peer-reviewed journals and book chapters

Ling SU, PhD

Regulatory

  • An epidemiologist and drug development professional with 25 years of industry and government experience in the US and Asia
  • He had held various research and managementpositions at Merck, Roche, Wyeth/Pfizer, Norvatis . His extensive experience spans the fields of regulatory affairs, medicinal product development strategy, clinical research, drug safety, and pharmacoepidemiology
  • He served as the DIA board President in 2012

Steve LANDAU, MD

Business Development

  • Dr. Landau has been in the biotechnology field for more than 20 years and is currently a Consultant in the health care field
  • He is a Senior Consultant to Ocumension (since 2017), a leading Ophthalmic Company in China
  • He was Founder and a Consulting Chief of Development for Convelo Therapeutics, focused on re-myelination, which in 2019 completed a collaboration and option to acquire agreement with Genentech/Roche Group
  • He is a summa cum laude graduate of Bowdoin College and a member of Phi Beta Kappa
  • He earned his MD from Case Western Reserve University in Cleveland Ohio graduating as a member of Alpha Omega Alpha